NCT03821220

Brief Summary

This three-arm clinical trial aims to improve levels of physical activity among Arabic- speaking residents of East Jerusalem with prediabetes. Levels of daily physical activity (assessed through activity trackers), dietary habits and self-assessed health will be compared between patients that receive only the activity tracker and written information (group A), receive the activity tracker, written information and a personalized physical activity prescription (group B), and those that receive in addition also intensive follow-up with motivational interview by physician assistants and a dietitian (group C)

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
375

participants targeted

Target at P75+ for not_applicable diabetes-mellitus

Timeline
Completed

Started Feb 2019

Typical duration for not_applicable diabetes-mellitus

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 24, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 29, 2019

Completed
17 days until next milestone

Study Start

First participant enrolled

February 15, 2019

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2021

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2021

Completed
Last Updated

February 5, 2019

Status Verified

February 1, 2019

Enrollment Period

2 years

First QC Date

January 24, 2019

Last Update Submit

February 3, 2019

Conditions

Keywords

Activity tracker; Arab population; Physical Activity

Outcome Measures

Primary Outcomes (1)

  • Physical activity level assessed through average weekly steps

    six months

Secondary Outcomes (13)

  • Fasting glucose levels

    six months

  • HbA1C levels

    six months

  • Body Mass Index

    six months

  • Lipid profile

    six months

  • Blood pressure

    six months

  • +8 more secondary outcomes

Study Arms (3)

Group A

ACTIVE COMPARATOR

Patients will receive an activity tracker and written information for pre-diabetic, on top of their usual care.

Behavioral: Activity tracker plus usual care

Group B

ACTIVE COMPARATOR

Patients will receive an activity tracker, written information for pre-diabetic, and personalized physical activity prescription, on top of their usual care.

Behavioral: Activity tracker plus usual careBehavioral: Personalized physical activity prescription

Group C

ACTIVE COMPARATOR

Patients will receive an activity tracker, written information for pre-diabetic, personalized physical activity prescription, three sessions of motivational interview support from trained physician assistants, and two session of dietitian support, on top of their usual care.

Behavioral: Motivational Interview support and Dietitian supportBehavioral: Activity tracker plus usual careBehavioral: Personalized physical activity prescription

Interventions

Three sessions of a structured motivational support intervention. Each patient will be required to set a SMART physical activity personal objective. The sessions will cover possible barriers and facilitators, enhancing self-efficacy, and feedback. In addition two sessions with a dietitian to discuss ways to improve current health habits.

Group C

Each patient will receive their own activity tracker (vivofit 3) with instructions on use, in addition to usual care, and written handouts for pre-diabetic patients.

Group AGroup BGroup C

Each patient will receive a personalized prescription of recommended physical activity including type of activity, duration and frequency.

Group BGroup C

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pre-diabetes patients - Impaired fasting glucose at least twice between 100-125 mg/dL in the two years prior to the study; or HbA1C 5.7%-6.4% twice in the two years prior to the study; or one test of fasting glucose of 100-125 mg/dL, and one test of HbA1C between 5.7%-6.4% in the two years prior to the study.

You may not qualify if:

  • Diabetes including a doctor's diagnosis based on a medical file or a recurrence of fasting blood glucose values above 126 mg/dL in the year preceding the study or a glucose value greater than 200 mg/dL in the year prior to the study or HbA1C above 6.5%
  • Treatment with diabetes drugs other than metformin, as prescribed in the medical file with regular or chronic medications
  • Artificial lower limbs or inability to walk normally (eg: stroke with plegia)
  • Chronic obstructive pulmonary disease
  • Known heart disease (with impaired exercise tolerance)
  • Pregnancy
  • Medical conditions:
  • a cardiac event/ Transient ischemic attack in the last year
  • Cerebrovascular attack with residual impairment
  • Surgery that required hospitalization in the last year
  • Injury to lower limbs that prevents regular walking
  • Malignancy excluding skin cancer small cell carcinoma or basal cell carcinoma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Diabetes MellitusMotor Activity

Interventions

Fitness Trackers

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBehavior

Intervention Hierarchy (Ancestors)

Diagnostic EquipmentEquipment and SuppliesWearable Electronic DevicesElectrical Equipment and Supplies

Study Officials

  • Amnon Lahad, MD

    Clalit

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Medical Quality unit and Chairman department of Family Medicine, Clalit Health Services, Jerusalem district

Study Record Dates

First Submitted

January 24, 2019

First Posted

January 29, 2019

Study Start

February 15, 2019

Primary Completion

February 15, 2021

Study Completion

August 31, 2021

Last Updated

February 5, 2019

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared